This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid007_D It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid007_D.html Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine. The full table of all monthly collections is: at house-of-papers.com PMC searches were done at moremed.org
1. Cardiac Manifestations Of Coronavirus (COVID-19)
PMC7278991 6. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
PMC7290348 10. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
18. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
54. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.
56. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}} {{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=}} {{tp|p=32380787|t=2020. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.|pdf=|usr=}} {{tp|p=32486196|t=2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?|pdf=|usr=}} {{tp|p=32455539|t=2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.|pdf=|usr=}} {{tp|p=32423094|t=2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?|pdf=|usr=}} {{tp|p=32393136|t=2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?|pdf=|usr=}} {{tp|p=32472662|t=2020. COVID-19 and diabetes: Is there enough evidence?|pdf=|usr=}} {{tp|p=32397558|t=2020. Impact of COVID-19 on the Cardiovascular System: A Review.|pdf=|usr=}} {{tp|p=32392741|t=2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.|pdf=|usr=}} {{tp|p=32443899|t=2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.|pdf=|usr=}} {{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=}} {{tp|p=32403255|t=2020. COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.|pdf=|usr=}} {{tp|p=32503180|t=2020. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.|pdf=|usr=}} {{tp|p=32498262|t=2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.|pdf=|usr=}} {{tp|p=32498230|t=2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.|pdf=|usr=}} {{tp|p=32496205|t=2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.|pdf=|usr=}} {{tp|p=32449782|t=2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32271393|t=2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.|pdf=|usr=}} {{tp|p=32482654|t=2020. Dr. Favalli, et al reply.|pdf=|usr=}} {{tp|p=32469410|t=2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32475878|t=2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.|pdf=|usr=}} {{tp|p=32475104|t=2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.|pdf=|usr=}} {{tp|p=32314329|t=2020. ACE-2 och coronavirus - en fraga om balans och dynamik?|pdf=|usr=}} {{tp|p=32471831|t=2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".|pdf=|usr=}} {{tp|p=32444383|t=2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.|pdf=|usr=}} {{tp|p=32467553|t=2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?|pdf=|usr=}} {{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=}} {{tp|p=32442932|t=2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.|pdf=|usr=}} {{tp|p=32481381|t=2020. A case report with COVID-19 during perioperative period of lobectomy.|pdf=|usr=}} {{tp|p=32443345|t=2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.|pdf=|usr=}} {{tp|p=32384516|t=2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.|pdf=|usr=}} {{tp|p=32502054|t=2020. A 3-month-old child with COVID-19: A case report.|pdf=|usr=}} {{tp|p=32502034|t=2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.|pdf=|usr=}} {{tp|p=32397692|t=2020. A case of Covid19 infection manifesting itself with only abdominal symptoms.|pdf=|usr=}} {{tp|p=32408731|t=2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.|pdf=|usr=}} {{tp|p=32380802|t=2020. Cardiovascular system and COVID-19: perspectives from a developing country.|pdf=|usr=}} {{tp|p=32449614|t=2020. Gender differences in patients with COVID-19: a narrative review.|pdf=|usr=}} {{tp|p=32447949|t=2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.|pdf=|usr=}} {{tp|p=32432433|t=2020. Severity of COVID-19: The importance of being hypertensive.|pdf=|usr=}} {{tp|p=32425013|t=2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.|pdf=|usr=}} {{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=}} {{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=}} {{tp|p=32457226|t=2020. COVID-19 in MS: Initial observations from the Pacific Northwest.|pdf=|usr=}} {{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=}} {{tp|p=32414755|t=2020. COVID-19 and MS disease-modifying therapies.|pdf=|usr=}} {{tp|p=32432445|t=2020. The kidney in COVID-19: protagonist or figurant?|pdf=|usr=}} {{tp|p=32486188|t=2020. SARS-CoV-2 Infection and the Liver.|pdf=|usr=}} {{tp|p=32503140|t=2020. Human T leukaemia Type 1 and COVID-19.|pdf=|usr=}} {{tp|p=32384078|t=2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.|pdf=|usr=}} {{tp|p=32497090|t=2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.|pdf=|usr=}} {{tp|p=32420710|t=2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.|pdf=|usr=}} {{tp|p=32385979|t=2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.|pdf=|usr=}} {{tp|p=32491298|t=2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.|pdf=|usr=}} {{tp|p=32469263|t=2020. Nierensonomorphologie bei COVID-19 mit akuter Niereninsuffizienz.|pdf=|usr=}} {{tp|p=32458823|t=2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.|pdf=|usr=}} {{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=}} {{tp|p=32491116|t=2020. A brief-review of the risk factors for covid-19 severity.|pdf=|usr=}} {{tp|p=32491091|t=2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.|pdf=|usr=}} {{tp|p=32491053|t=2020. Diabetes and covid-19: more than the sum of two morbidities.|pdf=|usr=}} {{tp|p=32507709|t=2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.|pdf=|usr=}} {{tp|p=32512263|t=2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.|pdf=|usr=}} {{tp|p=32460453|t=2020. COVID-19 in Singapore - a case series from primary care.|pdf=|usr=}} {{tp|p=32466735|t=2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.|pdf=|usr=}} {{tp|p=32459857|t=2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?|pdf=|usr=}} {{tp|p=32506344|t=2020. Acute intestinal ischemia in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32463186|t=2020. Lungeembolisme ved covid-19.|pdf=|usr=}} {{tp|p=32460390|t=2020. Covid-19 in solid organ transplant recipients: A single center experience.|pdf=|usr=}} {{tp|p=32429038|t=2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.|pdf=|usr=}} {{tp|p=32395790|t=2020. COVID-19 and Cardiovascular diseases. Scoping review study.|pdf=|usr=}} {{tp|p=32395788|t=2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.|pdf=|usr=}} {{tp|p=32395787|t=2020. First case of imported and confirmed COVID-19 in Tunisia.|pdf=|usr=}} {{tp|p=32394689|t=2020. COVID-19, Renin-angiotensin System and Hematopoiesis.|pdf=|usr=}} {{tp|p=32490641|t=2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.|pdf=|usr=}} {{tp|p=32430957|t=2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.|pdf=|usr=}} {{tp|p=32450787|t=2020. Liver injury in COVID-19: The current evidence.|pdf=|usr=}} {{tp|p=32450785|t=2020. COVID-19 and digestive health.|pdf=|usr=}} {{tp|p=32501145|t=2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).|pdf=|usr=}} {{tp|p=32456286|t=2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.|pdf=|usr=}} {{tp|p=32403242|t=2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.|pdf=|usr=}}
83. The involvement of the central nervous system in patients with COVID-19.
85. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
101. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.
{{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=}} {{tp|p=32493200|t=2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.|pdf=|usr=}} {{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=}} {{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=}} {{tp|p=32396143|t=2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32435811|t=2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.|pdf=|usr=}} {{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=}} {{tp|p=32396963|t=2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?|pdf=|usr=}} {{tp|p=32512587|t=2020. Bleeding and Bleeding Risk in COVID-19.|pdf=|usr=}} {{tp|p=32512586|t=2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.|pdf=|usr=}} {{tp|p=32447301|t=2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.|pdf=|usr=}} {{tp|p=32455440|t=2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.|pdf=|usr=}} {{tp|p=32510876|t=2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.|pdf=|usr=}} {{tp|p=32510771|t=2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.|pdf=|usr=}} {{tp|p=32510756|t=2020. Hyponatremia: A Possible Immuno-Neuroendocrine Interface with COVID-19 in a Kidney Transplant Recipient.|pdf=|usr=}} {{tp|p=32500942|t=2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.|pdf=|usr=}} {{tp|p=32500922|t=2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.|pdf=|usr=}} {{tp|p=32500666|t=2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.|pdf=|usr=}} {{tp|p=32492485|t=2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.|pdf=|usr=}} {{tp|p=32400381|t=2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].|pdf=|usr=}} {{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=}} {{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=}} {{tp|p=32462990|t=2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.|pdf=|usr=}} {{tp|p=32314950|t=2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.|pdf=|usr=}} {{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=}} {{tp|p=32223839|t=2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].|pdf=|usr=}} {{tp|p=32065520|t=2020. [First case of neonate infected with novel coronavirus pneumonia in China].|pdf=|usr=}} {{tp|p=32294814|t=2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].|pdf=|usr=}} {{tp|p=32447934|t=2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].|pdf=|usr=}} {{tp|p=32418377|t=2020. [Clinical analysis of kidney injury in patients with COVID-19].|pdf=|usr=}}
113. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.
{{tp|p=32496259|t=2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.|pdf=|usr=}} {{tp|p=32393678|t=2020. COVID-19: Important Issues for Pediatricians.|pdf=|usr=}} {{tp|p=32412915|t=2020. Managing Children with Renal Diseases during COVID-19 Pandemic.|pdf=|usr=}} {{tp|p=32487797|t=2020. The seXY side of COVID-19: what is behind female protection?|pdf=|usr=}} {{tp|p=32487793|t=2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.|pdf=|usr=}} {{tp|p=32487789|t=2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.|pdf=|usr=}} {{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=}} {{tp|p=32449528|t=2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.|pdf=|usr=}} {{tp|p=32470210|t=2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.|pdf=|usr=}} {{tp|p=32463562|t=2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?|pdf=|usr=}} {{tp|p=32463545|t=2020. Obesity and COVID-19: an Italian snapshot.|pdf=|usr=}} {{tp|p=32445512|t=2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.|pdf=|usr=}} {{tp|p=32445496|t=2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.|pdf=|usr=}} {{tp|p=32428380|t=2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.|pdf=|usr=}} {{tp|p=32505551|t=2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.|pdf=|usr=}} {{tp|p=32507368|t=2020. SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?|pdf=|usr=}} {{tp|p=32469426|t=2020. African American children are at higher risk of COVID-19 infection.|pdf=|usr=}} {{tp|p=32453902|t=2020. Chilblains-like lesions and COVID-19.|pdf=|usr=}} {{tp|p=32445583|t=2020. Erythema multiforme-like lesions in children and COVID-19.|pdf=|usr=}} {{tp|p=32437077|t=2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?|pdf=|usr=}} {{tp|p=32501190|t=2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.|pdf=|usr=}} {{tp|p=32461198|t=2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?|pdf=|usr=}} {{tp|p=32505834|t=2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?|pdf=|usr=}} {{tp|p=32512122|t=2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.|pdf=|usr=}} {{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=}} {{tp|p=32454268|t=2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.|pdf=|usr=}} {{tp|p=32507399|t=2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.|pdf=|usr=}}
140. Familial cluster of SARS-CoV-2 infection associated with a railway journey.
145. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.
168. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.
187. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.
203. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.
{{tp|p=32463446|t=2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.|pdf=|usr=}} {{tp|p=32250460|t=2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.|pdf=|usr=}} {{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=}} {{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=}} {{tp|p=32484584|t=2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.|pdf=|usr=}} {{tp|p=32479103|t=2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.|pdf=|usr=}} {{tp|p=32467603|t=2020. Resistance of children to Covid-19. How?|pdf=|usr=}} {{tp|p=32463329|t=2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.|pdf=|usr=}} {{tp|p=32391998|t=2020. De eerste 29 COVID-19-patienten in de kliniek.|pdf=|usr=}} {{tp|p=32391997|t=2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.|pdf=|usr=}} {{tp|p=32395964|t=2020. Do's-and-don'ts bij COVID-19-coagulopathie.|pdf=|usr=}} {{tp|p=32498065|t=2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.|pdf=|usr=}} {{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=}} {{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=}} {{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=}} {{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=}} {{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=}} {{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=}} {{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=}} {{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=}} {{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=}} {{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=}} {{tp|p=32237206|t=2020. Obesity and its Implications for COVID-19 Mortality.|pdf=|usr=}} {{tp|p=32384387|t=2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.|pdf=|usr=}} {{tp|p=32384385|t=2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32459701|t=2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.|pdf=|usr=}} {{tp|p=32433453|t=2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32433451|t=2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.|pdf=|usr=}} {{tp|p=32496337|t=2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.|pdf=|usr=}} {{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=}} {{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=}} {{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=}} {{tp|p=32453702|t=2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.|pdf=|usr=}} {{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=}} {{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=}} {{tp|p=32482123|t=2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.|pdf=|usr=}} {{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32413201|t=2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.|pdf=|usr=}} {{tp|p=32495391|t=2020. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.|pdf=|usr=}} {{tp|p=32467457|t=2020. Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain.|pdf=|usr=}} {{tp|p=32467452|t=2020. ORCHIEPIDIDYMITIS IN A BOY WITH COVID-19.|pdf=|usr=}} {{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=}} {{tp|p=32404786|t=2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.|pdf=|usr=}} {{tp|p=32502128|t=2020. COVID-19-Associated Myocarditis in an Adolescent.|pdf=|usr=}} {{tp|p=32398569|t=2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.|pdf=|usr=}} {{tp|p=32433226|t=2020. The Role of Human Coronavirus Infection in Pediatric Acute Gastroenteritis.|pdf=|usr=}} {{tp|p=32433225|t=2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.|pdf=|usr=}} {{tp|p=32427645|t=2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.|pdf=|usr=}} {{tp|p=32404791|t=2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.|pdf=|usr=}} {{tp|p=32404780|t=2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.|pdf=|usr=}} {{tp|p=32384398|t=2020. COVID-19 in Neonates and Infants: Progression and Recovery.|pdf=|usr=}} {{tp|p=32384397|t=2020. Children Hospitalized With Severe COVID-19 in Wuhan.|pdf=|usr=}} {{tp|p=32384396|t=2020. Hematuria Associated With SARS-CoV-2 Infection in a Child.|pdf=|usr=}} {{tp|p=32492251|t=2020. Clinical manifestations of children with COVID-19: A systematic review.|pdf=|usr=}} {{tp|p=32483934|t=2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.|pdf=|usr=}} {{tp|p=32392382|t=2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.|pdf=|usr=}} {{tp|p=32439817|t=2020. Immune Thrombocytopenia (ITP) in a SARS-CoV-2 Positive Pediatric Patient.|pdf=|usr=}} {{tp|p=32409480|t=2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.|pdf=|usr=}} {{tp|p=32404431|t=2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.|pdf=|usr=}} {{tp|p=32380898|t=2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.|pdf=|usr=}} {{tp|p=32419564|t=2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.|pdf=|usr=}} {{tp|p=32449876|t=2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.|pdf=|usr=}} {{tp|p=32434874|t=2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32338566|t=2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.|pdf=|usr=}} {{tp|p=32286091|t=2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?|pdf=|usr=}} {{tp|p=32442308|t=2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.|pdf=|usr=}} {{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=}} {{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=}} {{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=}} {{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=}} {{tp|p=32391742|t=2020. Abdominal Imaging Findings in COVID-19: Preliminary Observations.|pdf=|usr=}} {{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=}} {{tp|p=32374550|t=2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.|pdf=|usr=}} {{tp|p=32374540|t=2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.|pdf=|usr=}} {{tp|p=32374539|t=2020. Pandemie de COVID-19 : aspects cardiologiques.|pdf=|usr=}} {{tp|p=32462846|t=2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.|pdf=|usr=}} {{tp|p=32462841|t=2020. Obesite et risque de COVID-19 severe.|pdf=|usr=}} {{tp|p=32432429|t=2020. COVID-19: elements de connaissances concernant les enfants.|pdf=|usr=}} {{tp|p=32401442|t=2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?|pdf=|usr=}} {{tp|p=32496707|t=2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.|pdf=|usr=}} {{tp|p=32348058|t=2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?|pdf=|usr=}} {{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=}} {{tp|p=32348050|t=2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.|pdf=|usr=}} {{tp|p=32348048|t=2020. COVID-19 : impact pediatrique.|pdf=|usr=}}
225. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
PMC7276823 243. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
PMC7283841 254. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.
PMC7270880 259. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.
PMC7219389 271. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
{{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=}} {{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=}} {{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=}} {{tp|p=32490886|t=2020. Is there a rationale for heparin use among severe COVID-19 patients?|pdf=|usr=}} {{tp|p=32453917|t=2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?|pdf=|usr=}} {{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=}} {{tp|p=32441243|t=2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.|pdf=|usr=}} {{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=}} {{tp|p=32458742|t=2020. Nurse infected with Covid-19 from a provisional dengue patient.|pdf=|usr=}} {{tp|p=32395943|t=2020. Pericarditis aguda secundaria a COVID-19.|pdf=|usr=}} {{tp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=}} {{tp|p=32467096|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.|pdf=|usr=}} {{tp|p=32429041|t=2020. COVID-19 and Gastrointestinal Symptoms-A Case Report.|pdf=|usr=}} {{tp|p=32474561|t=2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.|pdf=|usr=}} {{tp|p=32482915|t=2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.|pdf=|usr=}} {{tp|p=32436996|t=2020. The value of clinical parameters in predicting the severity of COVID-19.|pdf=|usr=}} {{tp|p=32427361|t=2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.|pdf=|usr=}} {{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=}} {{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=}} {{tp|p=32418216|t=2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.|pdf=|usr=}} {{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=}} {{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=}} {{tp|p=32510106|t=2020. Clinical Presentation of COVID19 in Dementia Patients.|pdf=|usr=}} {{tp|p=32418199|t=2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32470213|t=2020. All those D-dimers in COVID-19.|pdf=|usr=}} {{tp|p=32470207|t=2020. Frequency of lupus anticoagulant in Covid-19 patients.|pdf=|usr=}} {{tp|p=32470198|t=2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.|pdf=|usr=}} {{tp|p=32470154|t=2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.|pdf=|usr=}} {{tp|p=32464707|t=2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.|pdf=|usr=}} {{tp|p=32459046|t=2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.|pdf=|usr=}} {{tp|p=32426897|t=2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.|pdf=|usr=}} {{tp|p=32415902|t=2020. Ibuprofen and thromboembolism in SARS-COV2.|pdf=|usr=}} {{tp|p=32506364|t=2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.|pdf=|usr=}} {{tp|p=32504449|t=2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.|pdf=|usr=}} {{tp|p=32492092|t=2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.|pdf=|usr=}} {{tp|p=32505466|t=2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.|pdf=|usr=}} {{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=}} {{tp|p=32436600|t=2020. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure.|pdf=|usr=}} {{tp|p=32505846|t=2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?|pdf=|usr=}} {{tp|p=32512494|t=2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?|pdf=|usr=}} {{tp|p=32441063|t=2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.|pdf=|usr=}} {{tp|p=32507110|t=2020. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.|pdf=|usr=}} {{tp|p=32472989|t=2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?|pdf=|usr=}} {{tp|p=32508078|t=2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?|pdf=|usr=}} {{tp|p=32480326|t=2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?|pdf=|usr=}} {{tp|p=32480327|t=2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.|pdf=|usr=}} {{tp|p=32460086|t=2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.|pdf=|usr=}} {{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=}}
273. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.
283. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.
302. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.
{{tp|p=32510173|t=2020. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.|pdf=|usr=}} {{tp|p=32497344|t=2020. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.|pdf=|usr=}} {{tp|p=32497334|t=2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.|pdf=|usr=}} {{tp|p=32497298|t=2020. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.|pdf=|usr=}} {{tp|p=32497297|t=2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.|pdf=|usr=}} {{tp|p=32497290|t=2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.|pdf=|usr=}} {{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=}} {{tp|p=32508329|t=2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.|pdf=|usr=}} {{tp|p=32500549|t=2020. Clinical update on COVID-19 in pregnancy: A review article.|pdf=|usr=}} {{tp|p=32423324|t=2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.|pdf=|usr=}} {{tp|p=32427809|t=2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.|pdf=|usr=}} {{tp|p=32390643|t=2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?|pdf=|usr=}} {{tp|p=32441753|t=2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32441743|t=2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.|pdf=|usr=}} {{tp|p=32504532|t=2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.|pdf=|usr=}} {{tp|p=32479632|t=2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.|pdf=|usr=}} {{tp|p=32401228|t=2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?|pdf=|usr=}} {{tp|p=32404798|t=2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.|pdf=|usr=}} {{tp|p=32495985|t=2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.|pdf=|usr=}} {{tp|p=32348627|t=2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=}} {{tp|p=32432681|t=2020. Nasal ACE2 Levels and COVID-19 in Children.|pdf=|usr=}} {{tp|p=32391864|t=2020. COVID-19 and Racial/Ethnic Disparities.|pdf=|usr=}} {{tp|p=32215579|t=2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.|pdf=|usr=}} {{tp|p=32511673|t=2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.|pdf=|usr=}} {{tp|p=32250408|t=2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.|pdf=|usr=}} {{tp|p=32293639|t=2020. COVID-19 and African Americans.|pdf=|usr=}} {{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=}} {{tp|p=32401283|t=2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.|pdf=|usr=}} {{tp|p=32392288|t=2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.|pdf=|usr=}} {{tp|p=32511066|t=2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.|pdf=|usr=}} {{tp|p=32369410|t=2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.|pdf=|usr=}} {{tp|p=32394850|t=2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].|pdf=|usr=}} {{tp|p=32392591|t=2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.|pdf=|usr=}} {{tp|p=32471013|t=2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.|pdf=|usr=}} {{tp|p=32495496|t=2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?|pdf=|usr=}} {{tp|p=32502316|t=2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.|pdf=|usr=}} {{tp|p=32485314|t=2020. Persistent SARS-CoV-2 infection and the risk for cancer.|pdf=|usr=}} {{tp|p=32512287|t=2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.|pdf=|usr=}} {{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=}} {{tp|p=32320565|t=2020. First Case of Covid-19 in the United States. Reply.|pdf=|usr=}} {{tp|p=32320563|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=}} {{tp|p=32320562|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=}} {{tp|p=32320561|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=}} {{tp|p=32320560|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=}} {{tp|p=32320559|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=}} {{tp|p=32220206|t=2020. Clinical Characteristics of Covid-19 in China. Reply.|pdf=|usr=}} {{tp|p=32220205|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=}} {{tp|p=32220204|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=}} {{tp|p=32220203|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=}} {{tp|p=32220202|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=}} {{tp|p=32402156|t=2020. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.|pdf=|usr=}} {{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=}} {{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32427431|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.|pdf=|usr=}} {{tp|p=32427430|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=}} {{tp|p=32427429|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=}} {{tp|p=32427428|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=}} {{tp|p=32329974|t=2020. Mild or Moderate Covid-19.|pdf=|usr=}} {{tp|p=32427903|t=2020. How to address the coronavirus's outsized toll on people of colour.|pdf=|usr=}} {{tp|p=32393875|t=2020. Coronavirus blood-clot mystery intensifies.|pdf=|usr=}} {{tp|p=32265541|t=2020. Why measles deaths are surging - and coronavirus could make it worse.|pdf=|usr=}} {{tp|p=32395965|t=2020. Een man met dyspneu na een COVID-19-pneumonie.|pdf=|usr=}}
PMC7274513 337. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.
PMC7283786 364. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.
PMC7283873 365. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
PMC7283752 369. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.
PMC7245232 390. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.
{{tp|p=32503617|t=2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.|pdf=|usr=}} {{tp|p=32403153|t=2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.|pdf=|usr=}} {{tp|p=32449179|t=2020. Mortality in Older Patients with COVID-19.|pdf=|usr=}} {{tp|p=32441771|t=2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.|pdf=|usr=}} {{tp|p=32445276|t=2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.|pdf=|usr=}} {{tp|p=32452050|t=2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.|pdf=|usr=}} {{tp|p=32459882|t=2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"|pdf=|usr=}} {{tp|p=32455499|t=2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.|pdf=|usr=}} {{tp|p=32455485|t=2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.|pdf=|usr=}} {{tp|p=32455475|t=2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.|pdf=|usr=}} {{tp|p=32453865|t=2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).|pdf=|usr=}} {{tp|p=32452545|t=2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.|pdf=|usr=}} {{tp|p=32452542|t=2020. COVID-19 Presenting with Atypical Sweet's Syndrome.|pdf=|usr=}} {{tp|p=32441876|t=2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.|pdf=|usr=}} {{tp|p=32441830|t=2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.|pdf=|usr=}} {{tp|p=32434277|t=2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32428303|t=2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.|pdf=|usr=}} {{tp|p=32428291|t=2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?|pdf=|usr=}} {{tp|p=32426877|t=2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.|pdf=|usr=}} {{tp|p=32426864|t=2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.|pdf=|usr=}} {{tp|p=32421877|t=2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?|pdf=|usr=}} {{tp|p=32421876|t=2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?|pdf=|usr=}} {{tp|p=32450607|t=2020. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient.|pdf=|usr=}} {{tp|p=32436622|t=2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.|pdf=|usr=}} {{tp|p=32512022|t=2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.|pdf=|usr=}} {{tp|p=32512021|t=2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.|pdf=|usr=}} {{tp|p=32504736|t=2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.|pdf=|usr=}} {{tp|p=32458565|t=2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32459372|t=2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?|pdf=|usr=}} {{tp|p=32500773|t=2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.|pdf=|usr=}} {{tp|p=32470212|t=2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?|pdf=|usr=}} {{tp|p=32470211|t=2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?|pdf=|usr=}} {{tp|p=32470186|t=2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.|pdf=|usr=}} {{tp|p=32470174|t=2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.|pdf=|usr=}} {{tp|p=32470167|t=2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.|pdf=|usr=}} {{tp|p=32470156|t=2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.|pdf=|usr=}} {{tp|p=32462695|t=2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.|pdf=|usr=}} {{tp|p=32462689|t=2020. Features of enteric disease from human coronaviruses: Implications for COVID-19.|pdf=|usr=}} {{tp|p=32462663|t=2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.|pdf=|usr=}} {{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=}} {{tp|p=32449972|t=2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.|pdf=|usr=}} {{tp|p=32449792|t=2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.|pdf=|usr=}} {{tp|p=32445489|t=2020. COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=}} {{tp|p=32441816|t=2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32441789|t=2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32441787|t=2020. A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.|pdf=|usr=}} {{tp|p=32441773|t=2020. COVID-19 in a patient with HIV infection.|pdf=|usr=}} {{tp|p=32437017|t=2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.|pdf=|usr=}} {{tp|p=32437016|t=2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.|pdf=|usr=}} {{tp|p=32437004|t=2020. Hepatic complications of COVID-19 and its treatment.|pdf=|usr=}} {{tp|p=32437000|t=2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.|pdf=|usr=}} {{tp|p=32436998|t=2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.|pdf=|usr=}} {{tp|p=32505530|t=2020. Co-infection with an atypical pathogen of COVID-19 in a young.|pdf=|usr=}} {{tp|p=32505438|t=2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.|pdf=|usr=}} {{tp|p=32505908|t=2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.|pdf=|usr=}}
392. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.
414. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
418. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.
425. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.
440. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.
{{tp|p=32385130|t=2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.|pdf=|usr=}} {{tp|p=32467113|t=2020. Presentation and Outcomes of Patients with ESKD and COVID-19.|pdf=|usr=}} {{tp|p=32484893|t=2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.|pdf=|usr=}} {{tp|p=32448041|t=2020. Covid-19 induced superimposed bacterial infection.|pdf=|usr=}} {{tp|p=32453074|t=2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.|pdf=|usr=}} {{tp|p=32510598|t=2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.|pdf=|usr=}} {{tp|p=32433344|t=2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.|pdf=|usr=}} {{tp|p=32433342|t=2020. Cardiovascular Manifestation and Treatment in COVID-19.|pdf=|usr=}} {{tp|p=32502117|t=2020. Coronavirus disease 2019 in children: Current status.|pdf=|usr=}} {{tp|p=32474598|t=2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.|pdf=|usr=}} {{tp|p=32436948|t=2020. Subacute Thyroiditis After Sars-COV-2 Infection.|pdf=|usr=}} {{tp|p=32488958|t=2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.|pdf=|usr=}} {{tp|p=32488888|t=2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.|pdf=|usr=}} {{tp|p=32479133|t=2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.|pdf=|usr=}} {{tp|p=32406283|t=2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.|pdf=|usr=}} {{tp|p=32363967|t=2020. A challenging case of psoriasis flare-up after COVID-19 infection.|pdf=|usr=}} {{tp|p=32433220|t=2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.|pdf=|usr=}} {{tp|p=32394639|t=2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?|pdf=|usr=}} {{tp|p=32389027|t=2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.|pdf=|usr=}} {{tp|p=32506937|t=2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.|pdf=|usr=}} {{tp|p=32484624|t=2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?|pdf=|usr=}} {{tp|p=32468512|t=2020. COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels.|pdf=|usr=}} {{tp|p=32474947|t=2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.|pdf=|usr=}} {{tp|p=32510648|t=2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?|pdf=|usr=}} {{tp|p=32500642|t=2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".|pdf=|usr=}} {{tp|p=32495400|t=2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?|pdf=|usr=}} {{tp|p=32495368|t=2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.|pdf=|usr=}} {{tp|p=32491234|t=2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.|pdf=|usr=}} {{tp|p=32491223|t=2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.|pdf=|usr=}} {{tp|p=32488946|t=2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?|pdf=|usr=}} {{tp|p=32488910|t=2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.|pdf=|usr=}} {{tp|p=32506122|t=2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.|pdf=|usr=}} {{tp|p=32490807|t=2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.|pdf=|usr=}} {{tp|p=32502097|t=2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.|pdf=|usr=}} {{tp|p=32502096|t=2020. Are COVID-19 patients with hypertension at higher risk in China?|pdf=|usr=}} {{tp|p=32504747|t=2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=}} {{tp|p=32504741|t=2020. Does type of immunosupression influence the course of Covid-19 infection?|pdf=|usr=}} {{tp|p=32490559|t=2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.|pdf=|usr=}} {{tp|p=32462792|t=2020. Sex-based dimorphism in the SARS-CoV2 virulence.|pdf=|usr=}} {{tp|p=32452046|t=2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.|pdf=|usr=}} {{tp|p=32498135|t=2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.|pdf=|usr=}} {{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=}} {{tp|p=32498581|t=2020. Relationship between pregnancy and coronavirus: what we know.|pdf=|usr=}} {{tp|p=32223477|t=2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.|pdf=|usr=}} {{tp|p=32369209|t=2020. Clinical characteristics and outcomes of cancer patients with COVID-19.|pdf=|usr=}} {{tp|p=32497287|t=2020. Anticardiolipin antibodies and COVID-19-A case report from America.|pdf=|usr=}} {{tp|p=32497283|t=2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.|pdf=|usr=}} {{tp|p=32492209|t=2020. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.|pdf=|usr=}} {{tp|p=32492199|t=2020. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.|pdf=|usr=}} {{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32492188|t=2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.|pdf=|usr=}} {{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=}} {{tp|p=32484975|t=2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.|pdf=|usr=}} {{tp|p=32314808|t=2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=}} {{tp|p=32335609|t=2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.|pdf=|usr=}} {{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=}}
457. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.
PMC7283811 466. Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States.
{{tp|p=32409442|t=2020. Skin manifestations of COVID-19.|pdf=|usr=}} {{tp|p=32409440|t=2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.|pdf=|usr=}} {{tp|p=32409438|t=2020. Treating acute anxiety in patients with COVID-19.|pdf=|usr=}} {{tp|p=32409436|t=2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.|pdf=|usr=}} {{tp|p=32409434|t=2020. Renin-angiotensin system inhibitors in COVID-19.|pdf=|usr=}} {{tp|p=32393596|t=2020. COVID-19 and pulmonary hypertension.|pdf=|usr=}} {{tp|p=32393593|t=2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.|pdf=|usr=}} {{tp|p=32409435|t=2020. Coagulopathy in COVID-19.|pdf=|usr=}} {{tp|p=32452350|t=2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.|pdf=|usr=}} {{tp|p=32461326|t=2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.|pdf=|usr=}} {{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=}} {{tp|p=32409520|t=2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=}} {{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=}} {{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=}} {{tp|p=32456720|t=2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.|pdf=|usr=}} {{tp|p=32460395|t=2020. Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States.|pdf=|usr=}} {{tp|p=32447761|t=2020. Dermatological findings in COVID-19 patients: Mexican experience.|pdf=|usr=}} {{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=}} {{tp|p=32505779|t=2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?|pdf=|usr=}} {{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=}} {{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=}} {{tp|p=32449224|t=2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=}} {{tp|p=32512349|t=2020. Clinically significant anticardiolipin antibodies associated with COVID-19.|pdf=|usr=}}
475. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.
480. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).
511. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
547. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
{{tp|p=32242895|t=2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.|pdf=|usr=}} {{tp|p=32498078|t=2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.|pdf=|usr=}} {{tp|p=32423251|t=2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.|pdf=|usr=}} {{tp|p=32423249|t=2020. Physical activity/inactivity and COVID-19.|pdf=|usr=}} {{tp|p=32397803|t=2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.|pdf=|usr=}} {{tp|p=32475157|t=2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).|pdf=|usr=}} {{tp|p=32270698|t=2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32233671|t=2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.|pdf=|usr=}} {{tp|p=32495914|t=2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.|pdf=|usr=}} {{tp|p=32495913|t=2020. Severe acute dried gangrene in COVID-19 infection: a case report.|pdf=|usr=}} {{tp|p=32495849|t=2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?|pdf=|usr=}} {{tp|p=32441761|t=2020. COVID-19 and QT interval prolongation: more than just drug toxicity?|pdf=|usr=}} {{tp|p=32441223|t=2020. COVID-19 and obesity: links and risks.|pdf=|usr=}} {{tp|p=32511033|t=2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.|pdf=|usr=}} {{tp|p=32425184|t=2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.|pdf=|usr=}} {{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=}} {{tp|p=32420884|t=2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.|pdf=|usr=}} {{tp|p=32434831|t=2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.|pdf=|usr=}} {{tp|p=32430348|t=2020. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms.|pdf=|usr=}} {{tp|p=32414813|t=2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.|pdf=|usr=}} {{tp|p=32493828|t=2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.|pdf=|usr=}} {{tp|p=32464676|t=2020. Haemostasis in Times of COVID-19.|pdf=|usr=}} {{tp|p=32498097|t=2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.|pdf=|usr=}} {{tp|p=32431118|t=2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].|pdf=|usr=}} {{tp|p=32437224|t=2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.|pdf=|usr=}} {{tp|p=32461330|t=2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32461328|t=2020. Getting to the heart of the matter of COVID-19.|pdf=|usr=}} {{tp|p=32451360|t=2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.|pdf=|usr=}} {{tp|p=32499236|t=2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?|pdf=|usr=}} {{tp|p=32364920|t=2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.|pdf=|usr=}} {{tp|p=32473607|t=2020. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.|pdf=|usr=}} {{tp|p=32415860|t=2020. Liver Biochemistries in Hospitalized Patients With COVID-19.|pdf=|usr=}} {{tp|p=32512611|t=2020. Endocrine Conditions and COVID-19.|pdf=|usr=}} {{tp|p=32429774|t=2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.|pdf=|usr=}} {{tp|p=32456489|t=2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?|pdf=|usr=}} {{tp|p=32383626|t=2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.|pdf=|usr=}} {{tp|p=32383624|t=2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.|pdf=|usr=}} {{tp|p=32458694|t=2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.|pdf=|usr=}} {{tp|p=32493070|t=2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.|pdf=|usr=}} {{tp|p=32476472|t=2020. COVID-19: ACE2centric infective disease?|pdf=|usr=}} {{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=}} {{tp|p=32389131|t=2020. A case of COVID-19 with an ultralong incubation period.|pdf=|usr=}} {{tp|p=32427018|t=2020. Several neonates reported positive for COVID-19.|pdf=|usr=}} {{tp|p=32476551|t=2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?|pdf=|usr=}} {{tp|p=32476537|t=2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.|pdf=|usr=}} {{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=}} {{tp|p=32418532|t=2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.|pdf=|usr=}} {{tp|p=32389117|t=2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32348232|t=2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.|pdf=|usr=}} {{tp|p=32440692|t=2020. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=}} {{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=}} {{tp|p=32505331|t=2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?|pdf=|usr=}} {{tp|p=32506768|t=2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.|pdf=|usr=}} {{tp|p=32506743|t=2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.|pdf=|usr=}} {{tp|p=32496583|t=2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?|pdf=|usr=}} {{tp|p=32496578|t=2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.|pdf=|usr=}} {{tp|p=32363628|t=2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.|pdf=|usr=}} {{tp|p=32473603|t=2020. Maternal mortality from COVID-19 in Mexico.|pdf=|usr=}} {{tp|p=32438521|t=2020. Update on clinical outcomes of women with COVID-19 during pregnancy.|pdf=|usr=}} {{tp|p=32428290|t=2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.|pdf=|usr=}} {{tp|p=32510581|t=2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.|pdf=|usr=}} {{tp|p=32330289|t=2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.|pdf=|usr=}} {{tp|p=32510283|t=2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.|pdf=|usr=}} {{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=}} {{tp|p=32468166|t=2020. Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.|pdf=|usr=}} {{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=}} {{tp|p=32267662|t=2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population|pdf=|usr=}} {{tp|p=32483000|t=2020. COVID-19 pneumonia in patients with HIV - A Case Series.|pdf=|usr=}} {{tp|p=32404716|t=2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.|pdf=|usr=}} {{tp|p=32418475|t=2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.|pdf=|usr=}} {{tp|p=32250655|t=2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.|pdf=|usr=}} {{tp|p=32497704|t=2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=}} {{tp|p=32482887|t=2020. Haemorrhagic enteritis and COVID-19: causality or coincidence.|pdf=|usr=}} {{tp|p=32511148|t=2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.|pdf=|usr=}} {{tp|p=32364930|t=2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.|pdf=|usr=}} {{tp|p=32364928|t=2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.|pdf=|usr=}} {{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=}} {{tp|p=32441246|t=2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?|pdf=|usr=}} {{tp|p=32356516|t=2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.|pdf=|usr=}} {{tp|p=32484776|t=2020. COVID-19 and obstructive sleep apnea.|pdf=|usr=}} {{tp|p=32347205|t=2020. Narcolepsy and COVID-19: sleeping on an opportunity?|pdf=|usr=}} {{tp|p=32449619|t=2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.|pdf=|usr=}} {{tp|p=32436736|t=2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.|pdf=|usr=}} {{tp|p=32391713|t=2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?|pdf=|usr=}}
561. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.
PMC7280717 565. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.
PMC7270805 578. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.
PMC7280634 587. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.
PMC7280577 594. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).
{{tp|p=32464084|t=2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.|pdf=|usr=}} {{tp|p=32415815|t=2020. Lessons Learned from COVID-19 Pandemic in Italy.|pdf=|usr=}} {{tp|p=32468942|t=2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.|pdf=|usr=}} {{tp|p=32454503|t=2020. Stroke in COVID-19 and SARS-CoV-1.|pdf=|usr=}} {{tp|p=32438476|t=2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.|pdf=|usr=}} {{tp|p=32421857|t=2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.|pdf=|usr=}} {{tp|p=32505730|t=2020. Uncommon presentation of COVID-19: Gastrointestinal bleeding.|pdf=|usr=}} {{tp|p=32508062|t=2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.|pdf=|usr=}} {{tp|p=32508037|t=2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.|pdf=|usr=}} {{tp|p=32508034|t=2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.|pdf=|usr=}} {{tp|p=32508024|t=2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.|pdf=|usr=}} {{tp|p=32508041|t=2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.|pdf=|usr=}} {{tp|p=32507407|t=2020. COVID 19-An eye on the virus.|pdf=|usr=}} {{tp|p=32505211|t=2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.|pdf=|usr=}} {{tp|p=32467423|t=2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.|pdf=|usr=}} {{tp|p=32458546|t=2020. Cutaneous manifestations of COVID-19: A review of the published literature.|pdf=|usr=}} {{tp|p=32447798|t=2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?|pdf=|usr=}} {{tp|p=32505652|t=2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.|pdf=|usr=}} {{tp|p=32505980|t=2020. Relationship between COVID-19 and obesity.|pdf=|usr=}} {{tp|p=32469464|t=2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.|pdf=|usr=}} {{tp|p=32463179|t=2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.|pdf=|usr=}} {{tp|p=32463166|t=2020. Why is hyperglycemia worsening COVID-19 and its prognosis?|pdf=|usr=}} {{tp|p=32451317|t=2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.|pdf=|usr=}} {{tp|p=32506222|t=2020. COVID-19: Impact of and on Diabetes.|pdf=|usr=}} {{tp|p=32507692|t=2020. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases.|pdf=|usr=}} {{tp|p=32463538|t=2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.|pdf=|usr=}} {{tp|p=32438449|t=2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.|pdf=|usr=}} {{tp|p=32430971|t=2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?|pdf=|usr=}} {{tp|p=32507518|t=2020. Does active smoking worsen Covid-19?|pdf=|usr=}} {{tp|p=32460417|t=2020. COVID-19 - neurologists stay aware!|pdf=|usr=}} {{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=}} {{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=}} {{tp|p=32449248|t=2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.|pdf=|usr=}} {{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=}} {{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=}} {{tp|p=32505514|t=2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.|pdf=|usr=}} {{tp|p=32504135|t=2020. Point-of-care lung ultrasound in three neonates with COVID-19.|pdf=|usr=}}
598. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
632. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.
658. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
659. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.
{{tp|p=32339038|t=2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.|pdf=|usr=}} {{tp|p=32500721|t=2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.|pdf=|usr=}} {{tp|p=32482087|t=2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.|pdf=|usr=}} {{tp|p=32508261|t=2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.|pdf=|usr=}} {{tp|p=32469253|t=2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.|pdf=|usr=}} {{tp|p=32421381|t=2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.|pdf=|usr=}} {{tp|p=32412320|t=2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.|pdf=|usr=}} {{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=}} {{tp|p=32386189|t=2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.|pdf=|usr=}} {{tp|p=32386188|t=2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.|pdf=|usr=}} {{tp|p=32432563|t=2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.|pdf=|usr=}} {{tp|p=32406381|t=2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.|pdf=|usr=}} {{tp|p=32423908|t=2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32390405|t=2020. COVID-19 Viral Load of an Infected Family in China.|pdf=|usr=}} {{tp|p=32423903|t=2020. Thrombotic risk in COVID-19: a case series and case-control study.|pdf=|usr=}} {{tp|p=32414711|t=2020. The renin-angiotensin system - a therapeutic target in COVID-19?|pdf=|usr=}} {{tp|p=32503799|t=2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.|pdf=|usr=}} {{tp|p=32452757|t=2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?|pdf=|usr=}} {{tp|p=32512408|t=2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.|pdf=|usr=}} {{tp|p=32462940|t=2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.|pdf=|usr=}} {{tp|p=32468411|t=2020. COVID-19 and Asthma: Reflection During the Pandemic.|pdf=|usr=}} {{tp|p=32507883|t=2020. Covid-19: the renin-angiotensin system imbalance hypothesis.|pdf=|usr=}} {{tp|p=32459672|t=2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32463005|t=2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.|pdf=|usr=}} {{tp|p=32442082|t=2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.|pdf=|usr=}} {{tp|p=32448405|t=2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.|pdf=|usr=}} {{tp|p=32475056|t=2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.|pdf=|usr=}} {{tp|p=32475035|t=2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.|pdf=|usr=}} {{tp|p=32474988|t=2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.|pdf=|usr=}} {{tp|p=32424886|t=2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.|pdf=|usr=}} {{tp|p=32418320|t=2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.|pdf=|usr=}} {{tp|p=32406078|t=2020. COVID-19 in an elderly patient treated with secukinumab.|pdf=|usr=}} {{tp|p=32506813|t=2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.|pdf=|usr=}} {{tp|p=32500647|t=2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.|pdf=|usr=}} {{tp|p=32500589|t=2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.|pdf=|usr=}} {{tp|p=32500580|t=2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.|pdf=|usr=}} {{tp|p=32478942|t=2020. Covid-19 infection in psoriasis patients treated with cyclosporin.|pdf=|usr=}} {{tp|p=32430456|t=2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?|pdf=|usr=}} {{tp|p=32409505|t=2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.|pdf=|usr=}} {{tp|p=32409504|t=2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.|pdf=|usr=}} {{tp|p=32409502|t=2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.|pdf=|usr=}} {{tp|p=32409499|t=2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.|pdf=|usr=}} {{tp|p=32409498|t=2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.|pdf=|usr=}} {{tp|p=32496012|t=2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32482296|t=2020. COVID-19: Perspectives from people with diabetes.|pdf=|usr=}} {{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32423922|t=2020. More advice on the use of ibuprofen for COVID-19.|pdf=|usr=}} {{tp|p=32468357|t=2020. An unresponsive COVID-19 patient.|pdf=|usr=}} {{tp|p=32464652|t=2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?|pdf=|usr=}} {{tp|p=32464641|t=2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?|pdf=|usr=}} {{tp|p=32459851|t=2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.|pdf=|usr=}} {{tp|p=32441750|t=2020. Angioedema in COVID-19.|pdf=|usr=}} {{tp|p=32432700|t=2020. Return to sports after COVID-19 infection.|pdf=|usr=}} {{tp|p=32282026|t=2020. Call to action for the cardiovascular side of COVID-19.|pdf=|usr=}} {{tp|p=32498076|t=2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.|pdf=|usr=}} {{tp|p=32464642|t=2020. Myocardial injury in severe COVID-19 infection.|pdf=|usr=}} {{tp|p=32449762|t=2020. Acute coronary syndromes during COVID-19.|pdf=|usr=}} {{tp|p=32432723|t=2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.|pdf=|usr=}} {{tp|p=32432704|t=2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=}} {{tp|p=32462177|t=2020. Myocarditis detected after COVID-19 recovery.|pdf=|usr=}} {{tp|p=32464637|t=2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.|pdf=|usr=}} {{tp|p=32501480|t=2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.|pdf=|usr=}} {{tp|p=32501477|t=2020. Antihypertensive drugs in COVID-19 infection.|pdf=|usr=}} {{tp|p=32511752|t=2020. COVID-19 and End Stage Renal Disease.|pdf=|usr=}} {{tp|p=32511751|t=2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.|pdf=|usr=}} {{tp|p=32469251|t=2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?|pdf=|usr=}} {{tp|p=32453009|t=2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.|pdf=|usr=}} {{tp|p=32282549|t=2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.|pdf=|usr=}} {{tp|p=32485082|t=2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.|pdf=|usr=}} {{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=}} {{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=}} {{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=}} {{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=}} {{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=}}
673. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
PMC7272930 685. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.
PMC7283641 686. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.
PMC7217127 687. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.
PMC7261080 688. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.
PMC7280609 699. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
PMC7287299 709. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.
{{tp|p=32396903|t=2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?|pdf=|usr=}} {{tp|p=32238235|t=2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.|pdf=|usr=}} {{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=}} {{tp|p=32498096|t=2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.|pdf=|usr=}} {{tp|p=32470281|t=2020. La bronquiolitis en el ano del COVID-19.|pdf=|usr=}} {{tp|p=32505489|t=2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.|pdf=|usr=}} {{tp|p=32401850|t=2020. Coronavirus e o Coracao | Um Relato de Caso sobre a Evolucao da COVID-19 Associado a Evolucao Cardiologica.|pdf=|usr=}} {{tp|p=32401847|t=2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.|pdf=|usr=}} {{tp|p=32401844|t=2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.|pdf=|usr=}} {{tp|p=32491075|t=2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.|pdf=|usr=}} {{tp|p=32491074|t=2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.|pdf=|usr=}} {{tp|p=32491073|t=2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.|pdf=|usr=}} {{tp|p=32386125|t=2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.|pdf=|usr=}} {{tp|p=32458534|t=2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.|pdf=|usr=}} {{tp|p=32472827|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.|pdf=|usr=}} {{tp|p=32512532|t=2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.|pdf=|usr=}} {{tp|p=32453688|t=2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.|pdf=|usr=}} {{tp|p=32471884|t=2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.|pdf=|usr=}} {{tp|p=32467124|t=2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.|pdf=|usr=}} {{tp|p=32503812|t=2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=}} {{tp|p=32460349|t=2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.|pdf=|usr=}} {{tp|p=32469077|t=2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.|pdf=|usr=}} {{tp|p=32460350|t=2020. Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).|pdf=|usr=}} {{tp|p=32453889|t=2020. Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.|pdf=|usr=}} {{tp|p=32453877|t=2020. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32453861|t=2020. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?|pdf=|usr=}} {{tp|p=32438482|t=2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.|pdf=|usr=}} {{tp|p=32438458|t=2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.|pdf=|usr=}} {{tp|p=32420629|t=2020. Evans syndrome in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32420615|t=2020. Dynamic relationship between D-dimer and COVID-19 severity.|pdf=|usr=}} {{tp|p=32420614|t=2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.|pdf=|usr=}} {{tp|p=32420612|t=2020. COVID-19-associated immune thrombocytopenia.|pdf=|usr=}} {{tp|p=32420611|t=2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.|pdf=|usr=}} {{tp|p=32420609|t=2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.|pdf=|usr=}} {{tp|p=32420608|t=2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.|pdf=|usr=}} {{tp|p=32452530|t=2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.|pdf=|usr=}} {{tp|p=32408910|t=2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.|pdf=|usr=}} {{tp|p=32470162|t=2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.|pdf=|usr=}} {{tp|p=32427416|t=2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.|pdf=|usr=}}
717. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.
718. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.
719. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
761. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
766. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.
771. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).
778. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.
{{tp|p=32506683|t=2020. D-dimer triage for COVID-19.|pdf=|usr=}} {{tp|p=32412848|t=2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.|pdf=|usr=}} {{tp|p=32492436|t=2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.|pdf=|usr=}} {{tp|p=32444450|t=2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.|pdf=|usr=}} {{tp|p=32422078|t=2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.|pdf=|usr=}} {{tp|p=32338533|t=2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.|pdf=|usr=}} {{tp|p=32320546|t=2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.|pdf=|usr=}} {{tp|p=32506699|t=2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?|pdf=|usr=}} {{tp|p=32475091|t=2020. Cardiovascular conditions and COVID-19.|pdf=|usr=}} {{tp|p=32427288|t=2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.|pdf=|usr=}} {{tp|p=32462179|t=2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.|pdf=|usr=}} {{tp|p=32492712|t=2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.|pdf=|usr=}} {{tp|p=32376670|t=2020. Covid-19: the challenge of patient rehabilitation after intensive care.|pdf=|usr=}} {{tp|p=32366505|t=2020. Covid-19 and pregnancy.|pdf=|usr=}} {{tp|p=32439704|t=2020. Covid-19 and thrombosis: what do we know about the risks and treatment?|pdf=|usr=}} {{tp|p=32434891|t=2020. Covid-19 and cardiovascular disease.|pdf=|usr=}} {{tp|p=32398229|t=2020. Covid-19: Low skilled men have highest death rate of working age adults.|pdf=|usr=}} {{tp|p=32393504|t=2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.|pdf=|usr=}} {{tp|p=32357954|t=2020. Covid-19 is no worse in immunocompromised children, says NICE.|pdf=|usr=}} {{tp|p=32217618|t=2020. Covid-19: risk factors for severe disease and death.|pdf=|usr=}} {{tp|p=32213482|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=}} {{tp|p=32209544|t=2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.|pdf=|usr=}} {{tp|p=32327432|t=2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.|pdf=|usr=}} {{tp|p=32291260|t=2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.|pdf=|usr=}} {{tp|p=32303575|t=2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.|pdf=|usr=}} {{tp|p=32467101|t=2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.|pdf=|usr=}} {{tp|p=32378464|t=2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).|pdf=|usr=}} {{tp|p=32479680|t=2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.|pdf=|usr=}} {{tp|p=32497248|t=2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.|pdf=|usr=}} {{tp|p=32484907|t=2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.|pdf=|usr=}} {{tp|p=32484906|t=2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.|pdf=|usr=}} {{tp|p=32484901|t=2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.|pdf=|usr=}} {{tp|p=32479664|t=2020. A Case Series of MGUS and COVID-19.|pdf=|usr=}} {{tp|p=32468862|t=2020. Licking the lungs, biting the brain: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=}} {{tp|p=32475821|t=2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.|pdf=|usr=}} {{tp|p=32492174|t=2020. First case of acute pancreatitis related to SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32311273|t=2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.|pdf=|usr=}} {{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=}} {{tp|p=32493522|t=2020. The impact of the Covid-19 Pandemic on Stroke Volume.|pdf=|usr=}} {{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=}} {{tp|p=32471876|t=2020. Registries Offer Insights on COVID-19-Cancer Connection.|pdf=|usr=}} {{tp|p=32398243|t=2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.|pdf=|usr=}} {{tp|p=32427636|t=2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?|pdf=|usr=}} {{tp|p=32496364|t=2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?|pdf=|usr=}} {{tp|p=32427637|t=2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.|pdf=|usr=}} {{tp|p=32494800|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=}} {{tp|p=32490506|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=}} {{tp|p=32473085|t=2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.|pdf=|usr=}} {{tp|p=32473051|t=2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.|pdf=|usr=}} {{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=}} {{tp|p=32209890|t=2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.|pdf=|usr=}} {{tp|p=32432519|t=2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?|pdf=|usr=}} {{tp|p=32511019|t=2020. COVID-19 infection at nighttime.|pdf=|usr=}} {{tp|p=32498625|t=2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.|pdf=|usr=}} {{tp|p=32434385|t=2020. Cardiac Arrhythmias in COVID-19 Infection.|pdf=|usr=}} {{tp|p=32397816|t=2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.|pdf=|usr=}} {{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=}} {{tp|p=32473009|t=2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.|pdf=|usr=}} {{tp|p=32472683|t=2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).|pdf=|usr=}} {{tp|p=32472676|t=2020. Predictors for Severe COVID-19 Infection.|pdf=|usr=}} {{tp|p=32472138|t=2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.|pdf=|usr=}} {{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=}} {{tp|p=32459833|t=2020. Hospitalized patients with COVID-19 and HIV: a case series.|pdf=|usr=}} {{tp|p=32444880|t=2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.|pdf=|usr=}} {{tp|p=32442294|t=2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32442285|t=2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.|pdf=|usr=}} {{tp|p=32442265|t=2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.|pdf=|usr=}} {{tp|p=32442259|t=2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?|pdf=|usr=}} {{tp|p=32433729|t=2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.|pdf=|usr=}} {{tp|p=32211755|t=2020. Epidemiological and Clinical Predictors of COVID-19.|pdf=|usr=}} {{tp|p=32502247|t=2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?|pdf=|usr=}} {{tp|p=32444393|t=2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.|pdf=|usr=}}
PMC7280597 785. Clinical course of coronavirus disease-2019 in pregnancy.
{{tp|p=32441332|t=2020. Clinical course of coronavirus disease-2019 in pregnancy.|pdf=|usr=}} {{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=}} {{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=}} {{tp|p=32470948|t=2020. Why does COVID-19 disproportionately affect older people?|pdf=|usr=}} {{tp|p=32499448|t=2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.|pdf=|usr=}} {{tp|p=32507570|t=2020. Acute myocarditis associated with COVID-19 infection.|pdf=|usr=}} {{tp|p=32496339|t=2020. Lipase Elevation in Patients With COVID-19.|pdf=|usr=}} {{tp|p=32483005|t=2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.|pdf=|usr=}} {{tp|p=32445584|t=2020. Immune thrombocytopenia due to COVID-19 during pregnancy.|pdf=|usr=}} {{tp|p=32512038|t=2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.|pdf=|usr=}} {{tp|p=32459524|t=2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.|pdf=|usr=}} {{tp|p=32421367|t=2020. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.|pdf=|usr=}} {{tp|p=32396497|t=2020. COVID-19-associated SIADH: a clue in the times of pandemic!|pdf=|usr=}} {{tp|p=32491949|t=2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?|pdf=|usr=}} {{tp|p=32432918|t=2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.|pdf=|usr=}} {{tp|p=32401670|t=2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?|pdf=|usr=}} {{tp|p=32412303|t=2020. Is the kidney a target of SARS-CoV-2?|pdf=|usr=}} {{tp|p=32436646|t=2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.|pdf=|usr=}} {{tp|p=32503857|t=2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.|pdf=|usr=}}
804. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
809. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.
819. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.
823. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.
858. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.
859. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.
{{tp|p=32469504|t=2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.|pdf=|usr=}} {{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=}} {{tp|p=32420961|t=2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.|pdf=|usr=}} {{tp|p=32420955|t=2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.|pdf=|usr=}} {{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=}} {{tp|p=32420950|t=2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.|pdf=|usr=}} {{tp|p=32420949|t=2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.|pdf=|usr=}} {{tp|p=32420948|t=2020. SARS-CoV-2 infection in children in Parma.|pdf=|usr=}} {{tp|p=32420942|t=2020. COVID19: potential cardiovascular issues in pediatric patients.|pdf=|usr=}} {{tp|p=32420941|t=2020. Novel coronavirus infection and children.|pdf=|usr=}} {{tp|p=32420939|t=2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.|pdf=|usr=}} {{tp|p=32420934|t=2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.|pdf=|usr=}} {{tp|p=32420930|t=2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.|pdf=|usr=}} {{tp|p=32420925|t=2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?|pdf=|usr=}} {{tp|p=32474914|t=2020. Anxiety and depression levels among pregnant women with COVID-19.|pdf=|usr=}} {{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=}} {{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=}} {{tp|p=32470131|t=2020. The COVID-19 Rehabilitation Pandemic.|pdf=|usr=}} {{tp|p=32449420|t=2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.|pdf=|usr=}} {{tp|p=32508193|t=2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.|pdf=|usr=}} {{tp|p=32501851|t=2020. SARS-CoV-2 infection in a highly experienced person living with HIV.|pdf=|usr=}} {{tp|p=32501850|t=2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.|pdf=|usr=}} {{tp|p=32469614|t=2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.|pdf=|usr=}} {{tp|p=32407127|t=2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=}} {{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=}} {{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=}} {{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=}} {{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=}} {{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=}} {{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=}} {{tp|p=32383969|t=2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.|pdf=|usr=}} {{tp|p=32478611|t=2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".|pdf=|usr=}} {{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=}} {{tp|p=32511678|t=2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.|pdf=|usr=}} {{tp|p=32380565|t=2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?|pdf=|usr=}} {{tp|p=32438425|t=2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.|pdf=|usr=}} {{tp|p=32428964|t=2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.|pdf=|usr=}} {{tp|p=32403141|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.|pdf=|usr=}} {{tp|p=32503058|t=2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?|pdf=|usr=}} {{tp|p=32467494|t=2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.|pdf=|usr=}} {{tp|p=32467490|t=2020. The place of early rehabilitation in ICU for Covid-19.|pdf=|usr=}} {{tp|p=32396381|t=2020. COVID-19 Associated Pulmonary Aspergillosis.|pdf=|usr=}} {{tp|p=32510975|t=2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?|pdf=|usr=}} {{tp|p=32471004|t=2020. Early COVID-19 infection after lung transplantation.|pdf=|usr=}} {{tp|p=32471001|t=2020. COVID-19 in elderly kidney transplant recipients.|pdf=|usr=}} {{tp|p=32492753|t=2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.|pdf=|usr=}} {{tp|p=32483909|t=2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.|pdf=|usr=}} {{tp|p=32476258|t=2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.|pdf=|usr=}} {{tp|p=32431287|t=2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.|pdf=|usr=}} {{tp|p=32419694|t=2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.|pdf=|usr=}} {{tp|p=32500854|t=2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.|pdf=|usr=}} {{tp|p=32503849|t=2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.|pdf=|usr=}} {{tp|p=32503848|t=2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.|pdf=|usr=}} {{tp|p=32205336|t=2020. Are my patients with rheumatic diseases at higher risk of COVID-19?|pdf=|usr=}} {{tp|p=32354774|t=2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.|pdf=|usr=}} {{tp|p=32354773|t=2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.|pdf=|usr=}} {{tp|p=32321723|t=2020. What is the true incidence of COVID-19 in patients with rheumatic diseases?|pdf=|usr=}}
